Status:
UNKNOWN
Incidental Coronary Calcification Quality Improvement Project
Lead Sponsor:
Stanford University
Conditions:
Atherosclerotic Cardiovascular Disease
Coronary Artery Disease
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
This is a multi-center, randomized quality improvement project. At least 200 statin-naïve patients without a history of atherosclerotic cardiovascular disease with incidental coronary artery calcium (...
Eligibility Criteria
Inclusion
- Non-gated chest CT between 2014-2019
- The presence of CAC confirmed by manual review by an experienced radiologist
- Stanford affiliated primary care provider or endocrinologist for Stanford healthcare system patients and VA primary care provider for VA patients with at least 1 encounter since 2018
Exclusion
- Current or prior statin or PCSK9 inhibitor therapy
- Prior diagnosis of ASCVD (coronary artery disease, peripheral arterial disease, cerebrovascular disease, coronary/peripheral revascularization)
- Prior coronary imaging (cardiac CT, invasive coronary angiography)
- Dementia
- Metastatic cancer or active cancer undergoing chemotherapy
- History of medical nonadherence
Key Trial Info
Start Date :
March 30 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 15 2022
Estimated Enrollment :
173 Patients enrolled
Trial Details
Trial ID
NCT04789278
Start Date
March 30 2021
End Date
September 15 2022
Last Update
July 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford Hospital & Clinics
Stanford, California, United States, 94066